A monthly medication subscription is also a series of handoffs: from a storefront to a clinician, from a prescription to a pharmacy, and from a delivery to ongoing care. Healthy Living Clinic describes each of those steps, but not always consistently. Its homepage emphasizes a quick questionnaire and physician review; its FAQ describes checkout before the medical questionnaire and consultation. For someone deciding whether to enroll, the practical question is not simply what medicine is advertised, but who becomes responsible at each stage—and when payment becomes difficult to recover.
This review examines Healthy Living Clinic’s public documentation consulted October 19, 2026. The platform advertises injectable tirzepatide and semaglutide, principally as compounded preparations, with monthly subscriptions and independent prescribing professionals. It provides concrete prices, contact information and pharmacy details, which makes parts of the process understandable. Other details require direct confirmation, including the Standard tirzepatide price, actual state availability, the refund cutoff and the frequency of follow-up. The review follows those operational questions rather than treating the purchase page as a complete description of medical care.
At a glance
- Clinical responsibility
- Healthy Living Clinic says it connects users with independent licensed professionals, who alone make diagnosis, treatment and prescribing decisions.Sources: [13]
- Advertised monthly prices
- The homepage advertises tirzepatide Micro at $99 and other doses at $149, including medication, consultation, syringes and shipping; the Standard product page instead lists $199 monthly.
- Prescription products
- The homepage identifies its compounded formulations as not FDA approved and not generic versions of brand-name drugs.Sources: [8]
- Recurring billing
- Subscriptions renew automatically. The policy says charges continue even when required questionnaires, lab work or other requested information remain incomplete.Sources: [4]
The platform, the clinician and the pharmacy are separate roles
Healthy Living Clinic’s terms describe a connecting platform, not the entity making medical decisions. Its FAQ names Beluga Health, P.A., a Florida professional corporation with a Houston address, as a clinical partner. This distinction matters when asking who reviews medical history, signs a prescription or handles a treatment concern. Our guide to clinicians and telehealth platforms explains why those responsibilities should be identified separately rather than assumed to belong to the company collecting payment.
The site’s descriptions of clinical leadership are not uniform. The FAQ identifies Jonah Mink, MD, as chief medical officer and says he is licensed in all 50 states and Washington, DC. The homepage presents Patrick Conrad as a board-certified physician and Gregory Smith as supervising medical director. These are provider statements, not independently verified credentials. The documentation does not establish which named professional would review a particular patient or how the leadership titles relate to individual care assignments.
The corporate history also needs separating from the clinic’s age. The company says it has operated since 2011 and is based in Colorado, while its history dates the launch of Healthy Living Clinic’s GLP-1 and peptide offering to 2024. It also claims completion of LegitScript certification. These statements describe the business’s background and claimed certification; they do not independently verify its clinicians, pharmacies or patient outcomes.
Intake is described in two different sequences
The homepage invites visitors to complete roughly two minutes of medical history without a payment card to learn whether they might fit the program. It then describes review by a board-certified, state-licensed physician, with prescribing only when appropriate. The FAQ gives a different sequence: check out, complete a health questionnaire, then consult with a professional to confirm eligibility. A preliminary no-card quiz therefore should not be mistaken for a completed clinical assessment or evidence that payment always follows medical approval.
The FAQ says the post-purchase professional could be a physician or nurse practitioner and will assess suitability and contraindications. Its advertised program criteria are age 18 or older and BMI of at least 25, with medical-history review. Those are the provider’s screening criteria, not a promise of a prescription. The consulted documentation does not explain required laboratory tests, whether testing costs extra, or a guaranteed review time. Asking these questions before checkout would make the sequence considerably clearer.
Location is another unresolved intake issue. The FAQ’s specific list covers most states and Washington, DC, but omits California, Kansas, Mississippi and New Jersey. It separately lists Guam, Puerto Rico and the US Virgin Islands, yet elsewhere claims service in all 50 states. A statement about a clinician’s nationwide licensure does not resolve that discrepancy. Before paying, residents should confirm availability for their address, intended product and dispensing arrangement rather than rely on the broad nationwide wording.
Confirm the prescribed product, not just the ingredient
The concrete offerings reviewed include tirzepatide described as a subcutaneous injection and semaglutide presented as an injectable product made by a US compounding pharmacy. The semaglutide page displays 2 mg or 4 mg customized presentations, but does not establish the volume, vial count or exact physical supply associated with a monthly charge. Those labels are not administration instructions. Although broader semaglutide copy mentions an oral route, the consulted purchase offering does not establish a purchasable oral option.
The homepage explicitly says its compounded formulations are not FDA-approved products or generic versions of branded drugs. It also describes microdosing as off-label. Meanwhile, the FAQ says the team prescribes both FDA-approved and nonapproved compounded GLP-1 medicines without identifying specific purchasable branded products in that passage. The useful next step is to request the exact product, formulation, route and pharmacy proposed for the prescription—not infer those details from the ingredient name or a general statement about the team’s prescribing scope.
FDA guidance provides context, not a provider-specific judgment: compounded preparations do not undergo FDA premarket review for safety, effectiveness and quality. FDA recommends them when an individual’s medical needs cannot be met by an approved drug. Nonapproval alone does not prove clinical inequivalence. Healthy Living Clinic’s own disclosure is useful, but it does not establish that a particular compounded prescription meets an individual’s needs. Our formulation checklist organizes the product questions to bring to the prescriber and pharmacy.
What the monthly payment is supposed to cover
The homepage bundles tirzepatide medication, consultation, syringes and shipping, with no membership fee. Its Micro price is $99 monthly; it advertises $149 monthly for other doses, including Standard. Product listings, however, show Micro at $99, Intermediate at $149 and Standard at $199 monthly. The Standard discrepancy is material, not a minor difference in wording. Obtain the product name, current charge and expected renewal amount in writing before authorizing payment.
The semaglutide listing shows $149 monthly, reduced from a displayed original $299. Its description explicitly ties $149 to what is needed for the first month and lists medication, consultation, shipping and a syringe kit as subscription inclusions. The tirzepatide listings likewise display higher crossed-out original prices, but the quoted blocks do not establish when those discounts end. None of this documents a permanent rate guarantee, an exact supply quantity or the cost of any required outside testing.
The homepage says plans are month to month, without a three-, six- or twelve-month commitment or long-term prepayment to unlock a rate. Yet its table says one month is due today, despite marketing language suggesting nothing is payable upfront. The sensible reading is not a free first month: distinguish an initial monthly charge from multi-month prepayment. Insurance acceptance, insurer reimbursement, prior authorization assistance and HSA/FSA payment are not established in the consulted documentation.
| Offering | Published price | Detail to confirm |
|---|---|---|
| Tirzepatide Micro | $99/month; displayed original $299 | Exact formulation and dispensed quantity |
| Tirzepatide Intermediate | $149/month; displayed original $349 | Renewal amount and included supply |
| Tirzepatide Standard | $149/month on homepage; $199/month on product page, displayed original $500 | Which price applies at checkout and renewal |
| Injectable semaglutide | $149/month; displayed original $299 | First-month contents and subsequent prescription arrangements |
The pharmacy handoff needs more than a delivery estimate
The homepage says a US compounding pharmacy fills prescriptions and advertises delivery in three to five business days with syringes included. The FAQ instead says receipt takes about a week for the contiguous 48 states. Another homepage heading uses dispatch language, so these statements should not be combined into a guaranteed end-to-end schedule. Clinical review, dispensing, dispatch and arrival are separate stages, and the documentation does not provide a guaranteed timetable for each.
The contact page identifies Belmar Pharmacy at 12012 N 111th Avenue in Youngtown, Arizona, with telephone 1-800-699-8143 and fax 1-800-330-0268. Listed hours are Monday through Friday, 8 a.m.–6 p.m. Mountain Time, and Saturday, 9 a.m.–noon, with Sunday closed. Naming a pharmacy creates a useful contact path, but does not establish that Belmar handles every prescription. Ask which pharmacy will dispense the actual order and who will address a delay, damaged package or prescription discrepancy.
The consulted pages do not specify the carrier, refrigeration packaging, tracking arrangements or special logistics for Alaska, Hawaii and territories. Our pharmacy-handoff guide explains the questions worth settling before fulfillment. For injectable GLP-1 medication arriving warm or with insufficient refrigeration, FDA explicitly recommends not using it and contacting the provider or dispensing pharmacy. An advertised shipping interval or included delivery fee does not answer whether a particular shipment remained appropriately refrigerated.
Follow-up is offered, but its schedule is not defined
The FAQ says the medical professional remains available for follow-up questions primarily through the Healthy Living Clinic portal. It also advertises community access, meal plans, workouts, coaching, customized health protocols and a monthly progress tracker. These are different kinds of support: a tracker or community resource is not the same as a scheduled clinical review. The documentation does not establish a mandatory consultation frequency, guaranteed clinician response time or clearly defined escalation process for unanswered medical questions.
That uncertainty matters because the billing policy says recurring charges continue even when required questionnaires, laboratory work or other requested information have not been completed. Patient delays do not automatically pause, defer or cancel billing. Before enrolling, ask which tasks are necessary for another prescription, when they are due and what happens to both medication fulfillment and charges while review is pending. A subscription can remain financially active without the documentation establishing that every clinical or dispensing step has been completed.
NIDDK describes follow-up as attention to response and tolerability, not just continued payment. For this service, the practical preparation is to identify the clinical messaging route and distinguish it from customer service. General support is listed at help@healthyliving.clinic and 800-599-3104, with a mailing address of 1990 Depew St. #140690, Edgewater, CO 80214. Those are useful administrative contacts, but their publication does not establish clinical availability or a guaranteed answer time.
Stopping the subscription and recovering a payment are different
Subscriptions automatically renew until canceled. The homepage promises cancellation through the portal without a phone call or emailed form, but the policy requires contacting customer service at least five days before the next billing date. The terms instead measure five days against the next scheduled shipment and exclude prorated refunds for mid-cycle cancellation. These differences leave both the required action and controlling date uncertain. Request confirmation of the cancellation method, deadline and effective date, and retain the resulting record.
The policy promises a full purchase refund when the medical provider determines the customer is not a suitable candidate. After approval, however, its language conflicts. One clause offers a best-effort attempt to stop a prescription before shipment, with a full refund if successful, but excludes orders already processed or in transit. Another says the order becomes final and nonrefundable upon prescription approval, except where legally required. The public documentation does not resolve which boundary governs an approved but unshipped order.
The semaglutide page adds a 60-day “Lose weight or You Don’t Pay” guarantee without explaining its conditions in that passage. It should not be treated as overriding the prescription refund exclusions or guaranteeing a particular outcome. Before relying on it, request the eligibility conditions, claim procedure, covered charges and interaction with cancellation rules. Our guide to changing or ending a program helps distinguish ending future payments from obtaining a refund for an existing order.
Privacy also follows the division of responsibilities
Healthy Living Clinic’s privacy policy says the platform itself is not a HIPAA covered entity. Independent medical providers or pharmacy partners may be covered entities, and the platform may act as their business associate in limited circumstances. That is more specific than a general “HIPAA Compliant” marketing statement. Before entering sensitive information, readers can ask which entity receives the medical questionnaire, where clinical messages are maintained and which privacy notice applies to the professional or pharmacy handling their care.
The policy also discloses advertising and retargeting tools, including Meta Pixel, and says cookies are placed automatically, with browser settings available to control or block them. This does not establish that particular medical information was disclosed to an advertiser, and the documentation should not be stretched into that accusation. It does establish a reason to distinguish browsing the storefront from communicating with a clinical provider. The platform’s administrative, advertising and clinical-partner relationships are not interchangeable.
Questions & answers
Can I check possible eligibility without paying?
The homepage offers a roughly two-minute health-history quiz without a card. However, the FAQ describes checkout before the full questionnaire and consultation. Treat the quiz as preliminary screening, not completed medical approval. Ask when payment is collected and which clinical review remains afterward.
Is Standard tirzepatide $149 or $199 a month?
Both amounts appear: the homepage advertises Standard within its $149 monthly offering, while the Standard Dose product listing shows $199 monthly, reduced from $500. The consulted documentation does not resolve the difference. Confirm the exact product, initial charge and renewal amount before authorizing payment.
Will Belmar Pharmacy definitely fill my prescription?
The contact page lists Belmar Pharmacy and provides its Arizona address, telephone, fax and hours. It does not say Belmar is the exclusive dispensing pharmacy. Ask which pharmacy will receive your prescription and use that pharmacy’s contact information for order-specific dispensing or delivery questions.
Does Healthy Living Clinic serve every state?
The FAQ claims all-state service, but its detailed list omits California, Kansas, Mississippi and New Jersey. It separately advertises Guam, Puerto Rico and the US Virgin Islands. Those statements are not fully consistent. Confirm service for your address and intended prescription before purchasing rather than assuming nationwide availability.
Does canceling in the portal guarantee a refund?
No. Portal cancellation is advertised, but separate provisions impose five-day notice and restrict refunds. The terms exclude prorated mid-cycle refunds, and the policy conflicts on whether approval or later processing makes a purchase final. Obtain written confirmation about both future renewals and any existing prescription order.
What happens if I have not finished requested lab work?
The policy says recurring billing continues despite incomplete laboratory work, questionnaires or other requested information. It does not establish the specific tests required, their cost or how an incomplete review affects shipment. Contact both the clinical team about outstanding requirements and customer service about billing; neither issue should be assumed resolved by the other.
Our assessment
Healthy Living Clinic documents more than a medication storefront: it identifies independent clinical responsibility, advertises bundled monthly services, names a pharmacy contact and offers portal-based follow-up. Those are useful starting points for understanding care delivery. The weaknesses occur at consequential handoffs, however—payment versus medical approval, the Standard price, geographic eligibility, pharmacy assignment and the point at which a purchase becomes nonrefundable. Before enrolling, obtain a written summary identifying the prescribed product, dispensing pharmacy, total initial and recurring charges, required follow-up, cancellation deadline and applicable refund rule. The public pages support a description of the advertised service, not verification of its credentials, delivery performance or treatment outcomes. Its suitability as a care arrangement depends partly on whether the provider can resolve these operational questions clearly before payment.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Healthy Living Clinic — about us ↗
- Healthy Living Clinic — refund cancellation policy ↗
- Healthy Living Clinic — privacy policy ↗
- Healthy Living Clinic — product/tirzepatide ↗
- Healthy Living Clinic — contact us ↗
- Healthy Living Clinic — official website ↗
- Healthy Living Clinic — product/semaglutide ↗
- Healthy Living Clinic — faqs ↗
- Healthy Living Clinic — product/tirzepatide intermediate ↗
- Healthy Living Clinic — product/tirzepatide microdosing ↗
- Healthy Living Clinic — terms and conditions ↗